Prebiotic Effect of an Infant Formula Supplemented with Galacto-Oligosaccharides: Randomized Multicenter Trial

Journal of the American College of Nutrition

Volumn 33, Issue 5, 2014, Pages 385-393

  Giovannini, Marcello ^a   Verduci, Elvira ^a   Gregori, Dario ^a   Ballali, Simonetta ^b   Soldi, Sara ^c   Ghisleni, Diana ^b   Riva, Enrica ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c AAT Advanced Analytical Technologies Srl   (Italy)

Author keywords

bifidogenic activity; Clostridium; galacto oligosaccharides; infant formula; prebiotic

Indexed keywords

GALACTOSE OLIGOSACCHARIDE; RNA 16S; GALACTOSE; OLIGOSACCHARIDE; PREBIOTIC AGENT;

AGALACTIA; ANTHROPOMETRY; APGAR SCORE; ARTICLE; ARTIFICIAL MILK; BABY FOOD; BACTERIAL COLONIZATION; BIFIDOBACTERIUM; BREAST FEEDING; BREAST MILK; CLOSTRIDIUM; COLIC; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DNA EXTRACTION; DOUBLE BLIND PROCEDURE; ENDOCRINE BREAST DISEASE; ESCHERICHIA COLI; FEMALE; FEVER; FOOD REGURGITATION; GASTROINTESTINAL DISEASE; GENETIC CODE; HUMAN; INFANT; INTESTINE FLORA; LACTOBACILLUS; MALE; MICROBIOLOGICAL EXAMINATION; NORMAL HUMAN; NUTRITIONAL ASSESSMENT; PATHOLOGICAL CRYING; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SKIN DISEASE; VOMITING; BACTERIUM; CLINICAL TRIAL; DEFECATION; DRUG EFFECTS; FECES; GROWTH, DEVELOPMENT AND AGING; INFANT NUTRITION; INTESTINE; ITALY; MICROBIOLOGY; MULTICENTER STUDY;

CLOSTRIDIUM;

BACTERIA; BREAST FEEDING; COLIC; DEFECATION; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FECES; FEMALE; GALACTOSE; HUMANS; INFANT; INFANT FORMULA; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INTESTINES; ITALY; MALE; MILK, HUMAN; OLIGOSACCHARIDES; PREBIOTICS;

EID: 84919571339     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2013.878232     Document Type: Article

References (46)

1. Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics 129:e827–e841, 2012.
2. World Health Organization: “The Optimal Duration of Exclusive Breastfeeding. Report of an Expert Consultation.” Geneva: World Health Organization, March 28–30, 2001.
3. D’Auria E, Agostoni C, Giovannini M, Riva E, Zetterstrom R, Fortin R, Greppi GF, Bonizzi L, Roncada P: Proteomic evaluation of milk from different mammalian species as a substitute for breast milk. Acta Paediatr 94:1708–1713, 2005.
4. Koletzko B, Baker S, Cleghorn G, Neto UF, Gopalan S, Hernell O, Hock QS, Jirapinyo P, Lonnerdal B, Pencharz P, Pzyrembel H, Ramirez-Mayans J, Shamir R, Turck D, Yamashiro Y, Zong-Yi D: Global standard for the composition of infant formula: recommendations of an ESPGHAN coordinated international expert group. J Pediatr Gastroenterol Nutr 41:584–599, 2005.
5. Noverr MC, Huffnagle GB: The “microflora hypothesis” of allergic diseases. Clin Exp Allergy 35:1511–1520, 2005.
6. Fanaro S, Marten B, Bagna R, Vigi V, Fabris C, Pena-Quintana L, Arguelles F, Scholz-Ahrens KE, Sawatzki G, Zelenka R, Schrezenmeir J, de Vrese M, Bertino E: Galacto-oligosaccharides are bifidogenic and safe at weaning: a double-blind randomized multicenter study. J Pediatr Gastroenterol Nutr 48:82–88, 2009.
7. Agostoni C, Axelsson I, Goulet O, Koletzko B, Michaelsen KF, Puntis JW, Rigo J, Shamir R, Szajewska H, Turck D: Prebiotic oligosaccharides in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 39:465–473, 2004.
8. Boehm G, Moro G: Structural and functional aspects of prebiotics used in infant nutrition. J Nutr 138:1818S–1828S, 2008.
9. Knol J, Boehm G, Lidestri M, Negretti F, Jelinek J, Agosti M, Stahl B, Marini A, Mosca F: Increase of faecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formula-fed preterm infants. Acta Paediatr 94:31–33, 2005.
10. Brunser O, Figueroa G, Gotteland M, Haschke-Becher E, Magliola C, Rochat F, Cruchet S, Palframan R, Gibson G, Chauffard F, Haschke F: Effects of probiotic or prebiotic supplemented milk formulas on fecal microbiota composition of infants. Asia Pac J Clin Nutr 15:368–376, 2006.
11. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, Bindels JG, Welling GW: Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 30:61–67, 2000.
12. Guaraldi F, Salvatori G: Effect of breast and formula feeding on gut microbiota shaping in newborns. Front Cell Infect Microbiol 2:94, 2012.
13. Bezirtzoglou E, Tsiotsias A, Welling GW: Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH). Anaerobe 17:478–482, 2011.
14. Knol J, Scholtens P, Kafka C, Steenbakkers J, Gro S, Helm K, Klarczyk M, Schöpfer H, Böckler HM, Wells J: Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr 40:36–42, 2005.
15. Bakker-Zierikzee AM, Alles MS, Knol J, Kok FJ, Tolboom JJ, Bindels JG: Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life. Br J Nutr 94:783–790, 2005.
16. Miniello VL, Moro GE, Armenio L: Prebiotics in infant milk formulas: new perspectives. Acta Paediatr 91:68–76, 2003.
17. Fanaro S, Vigi V: Infant formulas supplemented with prebiotics: intestinal microbiota and immune responses. Minerva Pediatr 60:327–335, 2008.
18. Braegger C, Chmielewska A, Decsi T, Kolacek S, Mihatsch W, Moreno L, Piescik M, Puntis J, Shamir R, Szajewska H, Turck D, van Goudoever J: Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr 52:238–250, 2011.
19. Lin HC: Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA 292:852–858, 2004.
20. Ashley C, Johnston WH, Harris CL, Stolz SI, Wampler JL, Berseth CL: Growth and tolerance of infants fed formula supplemented with polydextrose (PDX) and/or galactooligosaccharides (GOS): double-blind, randomized, controlled trial. Nutr J 11:38, 2012.
21. McMahon E, Reguly T: Canada's approach to functional foods. Health Law Can 32:29–34, 2011.
22. Huijsdens XW, Linskens RK, Mak M, Meuwissen SG, Vandenbroucke-Grauls CM, Savelkoul PH: Quantification of bacteria adherent to gastrointestinal mucosa by real-time PCR. J Clin Microbiol 40:4423–4427, 2002.
23. Haarman M, Knol J: Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl Environ Microbiol 71:2318–2324, 2005.
24. Malinen E, Rinttila T, Kajander K, Matto J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A: Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 100:373–382, 2005.
25. Willey SH, Bartlett JG: Cultures for Clostridium difficile in stools containing a cytotoxin neutralized by Clostridium sordellii antitoxin. J Clin Microbiol 10:880–884, 1979.
26. de Jong AE, Beumer RR, Rombouts FM: Optimizing sporulation of Clostridium perfringens. J Food Prot 65:1457–1462, 2002.
27. Ouwehand AC, Salminen S, Arvola T, Ruuska T, Isolauri E: Microbiota composition of the intestinal mucosa: association with fecal microbiota? Microbiol Immunol 48:497–500, 2004.
28. R Core Team: “R: A Language and Environment for Statistical Computing.” 2012. Accessed at: http://www.R-project.org/.
29. Lifschitz C: Prevention of excessive crying by intestinal microbiota programming. J Pediatr 163:1250–1252, 2013.
30. Lehtonen L, Korvenranta H, Eerola E: Intestinal microflora in colicky and noncolicky infants: bacterial cultures and gas–liquid chromatography. J Pediatr Gastroenterol Nutr 19:310–314, 1994.
31. Savino F, Cresi F, Pautasso S, Palumeri E, Tullio V, Roana J, Silvestro L,: Intestinal microflora in breastfed colicky and non-colicky infants. Acta Paediatr 93:825–829, 2004.
32. Rhoads JM, Fatheree NY, Norori J, Liu Y, Lucke JF, Tyson JE, Ferris MJ: Altered fecal microflora and increased fecal calprotectin in infants with colic. J Pediatr 155:823–828, 2009.
33. Chen J, Cai W, Feng Y: Development of intestinal bifidobacteria and lactobacilli in breast-fed neonates. Clin Nutr 26:559–566, 2007.
34. Xia Q, Williams T, Hustead D, Price P, Morrison M, Yu Z: Quantitative analysis of intestinal bacterial populations from term infants fed formula supplemented with fructo-oligosaccharides. J Pediatr Gastroenterol Nutr 55:314–320, 2012.
35. Rao S, Srinivasjois R, Patole S: Prebiotic supplementation in full-term neonates: a systematic review of randomized controlled trials. Arch Pediatr Adolesc Med 163:755–764, 2009.
36. Gibson GR, Wang X: Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 77:412–420, 1994.
37. Sherman PM, Cabana M, Gibson GR, Koletzko BV, Neu J, Veereman-Wauters G, Ziegler EE, Walker WA: Potential roles and clinical utility of prebiotics in newborns, infants, and children: proceedings from a global prebiotic summit meeting, New York City, June 27–28, 2008. J Pediatr 155:S61–S70, 2009.
38. Costalos C, Kapiki A, Apostolou M, Papathoma E: The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants. Early Hum Dev 84:45–49, 2008.
39. Alliet P, Scholtens P, Raes M, Hensen K, Jongen H, Rummens JL, Boehm G, Vandenplas Y: Effect of prebiotic galacto-oligosaccharide, long-chain fructo-oligosaccharide infant formula on serum cholesterol and triacylglycerol levels. Nutrition 23:719–723, 2007.
40. Ben XM, Zhou XY, Zhao WH, Yu WL, Pan W, Zhang WL, Wu SM, Van Beusekom CM, Schaafsma A: Supplementation of milk formula with galacto-oligosaccharides improves intestinal micro-flora and fermentation in term infants. Chin Med J (Engl) 117:927–931, 2004.
41. Savino F, Cresi F, Maccario S, Cavallo F, Dalmasso P, Fanaro S, Oggero R, Vigi V, Silvestro L: “Minor” feeding problems during the first months of life: effect of a partially hydrolysed milk formula containing fructo- and galacto-oligosaccharides. Acta Paediatr 91:86–90, 2003.
42. Savino F, Maccario S, Castagno E, Cresi F, Cavallo F, Dalmasso P, Fanaro S, Oggero R, Silvestro L: Advances in the management of digestive problems during the first months of life. Acta Paediatr 94:120–14, 2005.
43. Savino F, Cordisco L, Tarasco V, Locatelli E, Di Gioia D, Oggero R, Matteuzzi D: Antagonistic effect of Lactobacillus strains against gas-producing coliforms isolated from colicky infants. BMC Microbiol 11:157, 2011.
44. Reuter G: The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. Curr Issues Intest Microbiol 2:43–53, 2001.
45. Fanaro S, Chierici R, Guerrini P, Vigi V: Intestinal microflora in early infancy: composition and development. Acta Paediatr 91:48–55, 2003.
46. Mariat D, Firmesse O, Levenez F, Guimaraes V, Sokol H, Dore J, Corthier G, Furet JP: The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol 9:123, 2009.